Cover Image
市場調查報告書

腎臟疾病:全球臨床實驗趨勢

Kidney Disease Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 341579
出版日期 內容資訊 英文 152 Pages
訂單完成後即時交付
價格
Back to Top
腎臟疾病:全球臨床實驗趨勢 Kidney Disease Global Clinical Trials Review, H2, 2015
出版日期: 2015年09月10日 內容資訊: 英文 152 Pages
簡介

本報告提供腎臟疾病相關臨床研究最新趨勢相關分析、疾病與治療方法概要,及G7及E7各國的臨床實驗狀況、各地區與各階段的進行狀況、有潛力的贊助商、各企業及研究機關的研究進行狀況、有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

簡介

  • 腎臟疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:腎臟疾病臨床實驗數量的尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

各相位臨床實驗數量:G7各國

G7各國的臨床實驗數量:各相位

E7各國的臨床實驗數量:腎臟疾病臨床實驗數量的尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

各相位臨床實驗數量: E7各國

E7各國的臨床實驗數量:各相位

各相位臨床實驗數量

  • 各相位的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

未完成的臨床實驗

一定期間採用的實驗人數

贊助商的各種類的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 腎臟疾病治療藥

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Amgen Inc.
    • Sanofi
    • AbbVie Inc.
    • Pfizer Inc.
    • Astellas Pharma Inc.
    • Merck & Co., Inc.
    • AstraZeneca Plc
    • Bayer AG
  • 代表性研究機關/醫院臨床實驗概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Mayo Clinic
    • Seoul National University Hospital
    • Shiraz University of Medical Sciences
    • Tehran University of Medical Sciences
    • The National Institute of Allergy and Infectious Diseases
    • Austin Health
    • Vanderbilt University
    • Isfahan University of Medical Sciences
    • Medical University of Vienna

5大臨床實驗簡介

附錄

圖表

目錄
Product Code: GDHC2858CTIDB

GlobalData's clinical trial report, "Kidney Disease Global Clinical Trials Review, H2, 2015" provides an overview of Kidney Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Kidney Disease
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Kidney Disease
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Kidney Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Austin Health
      • Clinical Trial Overview of Austin Health
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Kidney Disease Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Kidney Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Kidney Disease Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015*
  • Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*

List of Figures

  • Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top